Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Theravance, Inc.”

369 pharma patents match "Theravance, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 369
Index total 30,257
Page 10 / 16

Quick answer

This filtered view shows 369 pharmaceutical patents matching "Theravance, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

369 results for “Theravance, Inc.” · 30,257 patents in full index Clear search

  1. US 7604944

    Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

    Theravance, Inc. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted

  2. US 7601690

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  3. US 7592355

    Quinolinone-carboxamide compounds as 5-HT, receptor agonists

    Theravance, Inc. · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted

  4. US 7585879

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted

  5. US 7585653

    Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

    Theravance, Inc. · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted

  6. US 7582765

    Aryl aniline β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted

  7. US 7572918

    Process for preparing substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds

    Theravance, Inc. · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted

  8. US 7569588

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  9. US 7569586

    Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  10. US 7566785

    Amidine substituted aryl aniline compounds

    Theravance, Inc. · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted

  11. US 7560469

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jul 14, 2009 · Expires Jul 9, 2029

    granted

  12. US 7557247

    Crystalline form of β2 adrenergic receptor agonist

    Theravance, Inc. · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  13. US 7557126

    Diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  14. US 7553971

    Aryl aniline β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  15. US 7553962

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  16. US 7550595

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  17. US 7544364

    Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin

    Theravance, Inc. · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted

  18. US 7534889

    5-HT4 receptor agonist compounds

    Theravance, Inc. · Granted May 19, 2009 · Expires May 14, 2029

    granted

  19. US 7531623

    Hydrochloride salts of a glycopeptide phosphonate derivative

    Theravance, Inc. · Granted May 12, 2009 · Expires May 7, 2029

    granted

  20. US 7528253

    Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  21. US 7524959

    Biphenyl derivatives

    Theravance, Inc. · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  22. US 7524962

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  23. US 7524965

    Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  24. US 7524880

    Crystalline form of a substituted pyrrolidine compound

    Theravance, Inc. · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.